UK launches world-first ‘subscription’ model for antibiotic supply
The UK is set to become the first country in the world to pay drug companies a fixed fee for supplying antibiotics in an effort to tackle the growing global crisis over resistance to the drugs. The aim is to give companies a better incentive to develop new antibiotics, which would be held back to treat patients who really need them, while restraining overprescribing that leads microbes to develop drug resistance.
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!